MabVax
MabVax provides a human antibody discovery platform that focuses on the clinical development of cancer therapeutic and diagnostic products.
Business Model:
Revenue: $2.1M
Employees: 11-50
Rankings
Industries / Tags:
Detailed MabVax Information
Geographic Data
Address: 11535 Sorrento Valley Road
City: San Diego
State: CA
Zip: 92121
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$11M
Raised Total:$52M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
MabVax provides a human antibody discovery platform that focuses on the clinical development of cancer therapeutic and diagnostic products.
Contact Phone:
+18582599405
Contact Email:
MabVax went public on 7/11/2018 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/11/2018
Ticker Symbol:
MBVX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2018 | Equity | $830k | 4/2015 | Post-IPO Equity | 1 | $11.6M |
Phillip Frost Phillip Frost Phillip Frost Phillip Frost |
2/2014 | Venture Round | $12.1M | 9/2013 | Grant | 1 | $1.8M |
National Institutes of Health National Institutes of Health |
1/2012 | Venture Round | 1 | - |
Biomark Capital Biomark Capital |
9/2009 | Venture Round | $500k | 4/2011 | Venture Round | $1.8M | 2/2008 | Series A | 1 | $8M |
GBP Capital GBP Capital |
7/2018 | Post-IPO Equity | 1 | $11M |
Boehringer Ingelheim Boehringer Ingelheim |
8/2010 | Grant | $1.1M | 5/2017 | Post-IPO Equity | $4.1M | 11/2012 | Series B | 2 | $5.3M |
Burrill &a; Company Numoda Capital Innovations Numoda Capital Innovations Burrill &a; Company Numoda Capital Innovations Numoda Capital Innovations |
2/2018 | Equity | $2.8M | 8/2017 | Equity | $2M | 3/2015 | Equity | $11.6M |
Opko Health |
8/2017 | Post-IPO Equity | $1.3M | 7/2014 | Venture Round | $3M | 1/2012 | Venture Round | 1 | - |
Biomark Capital Biomark Capital |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 5/2014 | Telik |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
